pharmaceuticals
| ‘Remdesivir Papers’ Allege Controversial Drug Used to Treat Service Members Led to 601 Deaths |
| A living WHO guideline on drugs for covid-19 |
| A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics |
| An overview of the MATH+, I-MASK+ and I-RECOVER Protocols — A Guide to the Management of COVID-19 |
| Case report study of the first five COVID-19 patients treated with remdesivir in France |
| Compassionate Use of Remdesivir for Patients with Severe Covid-19 |
| Coronavirus Disease 2019 (COVID-19) Treatment Guidelines |
| Coronavirus Disease 2019: Treatments Your Healthcare Provider Might Recommend for Severe Illness |
| COVID-19 Humanity Betrayal Memory Project |
| Information for Clinicians on Investigational Therapeutics for Patients with COVID-19 |
| Kolaviron (Kolaflavanone), apigenin, fisetin as potential Coronavirus inhibitors: In silico investigation |
| My Life in the Thrill Kill Medical Cult |
| New COVID-19 Treatments Add-On Payment (NCTAP) |
| News release: FDA Approves First Treatment for COVID-19 |
| Remdesivir for COVID-19: real-time meta analysis of 79 studies |
| Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial |
| Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial |
| Rush to Use Ventilators Killed Thousands of COVID Patients |
| Table 2e. Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19 |
| The Talented Mr. Pottinger: The US Intelligence Agent Who Pushed Lockdowns |
| What the Nurses Saw |
| WHO advises that ivermectin only be used to treat COVID-19 within clinical trials |
